Strategies for viral RNA stability: Live long and prosper

Trends in Genetics

Volumn 27, Issue 7, 2011, Pages 286-293

  Dickson, Alexa M ^a   Wilusz, Jeffrey ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEASE; VIRUS RNA;

GENE EXPRESSION; GENE EXPRESSION REGULATION; HOST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA DEGRADATION; RNA STABILITY; VIRUS TRANSCRIPTION;

ANIMALS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; RNA STABILITY; RNA, VIRAL; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 79959368183     PISSN: 01689525     EISSN: 01689525     Source Type: Journal    
DOI: 10.1016/j.tig.2011.04.003     Document Type: Review

References (88)

1. Garneau N.L., et al. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007, 8:113-126.
2. Goldstrohm A.C., Wickens M. Multifunctional deadenylase complexes diversify mRNA control. Nat. Rev. Mol. Cell Biol. 2008, 9:337-344.
3. Houseley J., et al. RNA-quality control by the exosome. Nat. Rev. Mol. Cell Biol. 2006, 9:529-539.
4. Chang J.H., et al. Structural and biochemical studies of the 5'→3' exoribonuclease Xrn1. Nat. Struct. Mol. Biol. 2011, 18:270-276.
5. Song M.G., et al. Multiple mRNA decapping enzymes in mammalian cells. Mol. Cell 2010, 40:423-432.
6. Maquat L.E., Gong C. Gene expression networks: competing mRNA decay pathways in mammalian cells. Biochem. Soc. Trans. 2009, 37:1287-1292.
7. van den Elzen A.M., et al. Dissection of Dom34-Hbs1 reveals independent functions in two RNA quality control pathways. Nat. Struct. Mol. Biol. 2010, 17:1446-1452.
8. Schaeffer D., van Hoof A. Different nuclease requirements for exosome-mediated degradation of normal and nonstop mRNAs. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2366-2371.
9. Clement S.L., et al. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol. Cell. Biol. 2011, 31:256-266.
10. Zucconi B.E., et al. Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation of bound RNA ligands. J. Biol. Chem. 2010, 285:39127-39139.
11. Gherzi R., et al. The role of KSRP in mRNA decay and microRNA precursor maturation. Wiley Interdisciplinary Rev.: RNA 2010, 1:230-239.
12. Ding S.W. RNA-based antiviral immunity. Nat. Rev. Immunol. 2010, 10:632-644.
13. Tomecki R., Dziembowski A. Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism. RNA 2010, 16:1692-1724.
14. Cheadle C., et al. Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability. BMC Genomics 2005, 6:75.
15. Bai Y., et al. Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7269-7274.
16. Chou C.F., et al. Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay. Mol. Cell. Biol. 2006, 26:3695-3706.
17. Daffis S., et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 2010, 2468:452-456.
18. Trcek T., Singer R.H. The cytoplasmic fate of an mRNP is determined cotranscriptionally: exception or rule?. Genes Dev. 2010, 24:1827-1831.
19. Law L.M., et al. Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions. J. Virol. 2010, 84:4504-4512.
20. Wang N., et al. Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-kappaB-independent. J. Biol. Chem. 2010, 285:6080-6090.
21. Gao G., et al. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 2002, 297:1703-1706.
22. Lee E.G., et al. A premature termination codon mutation at the C terminus of foamy virus Gag downregulates the levels of spliced pol mRNA. J. Virol. 2008, 82:1656-1664.
23. Belew A.T., et al. Endogenous ribosomal frameshift signals operate as mRNA destabilizing elements through at least two molecular pathways in yeast. Nucleic Acids Res. 2011, 39:2799-2808.
24. van Hemert M.J., et al. SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog. 2008, 4:e1000054.
25. Conrad N.K., et al. Mutational analysis of a viral RNA element that counteracts rapid RNA decay by interaction with the polyadenylate tail. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10412-10417.
26. Mitton-Fry R.M., et al. Poly(A) tail recognition by a viral RNA element through assembly of a triple helix. Science 2010, 330:1244-1247.
27. Ford L.P., Wilusz J. 3'-Terminal RNA structures and poly(U) tracts inhibit initiation by a 3'-->5' exonuclease in vitro. Nucleic Acids Res. 1999, 27:1159-1167.
28. Sarkar A., et al. Structural and functional properties of the vesicular stomatitis virus nucleoprotein-RNA complex as revealed by proteolytic digestion. Virology 2010, 401:61-69.
29. Sahin B.B., et al. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways. PLoS Pathog. 2010, 6:e1000799.
30. Abdelmohsen K., Gorospe M. Postranscritpional regulation of cancer traits by HuR. Wiley Interdisciplinary Rev.: RNA 2010, 1:214-229.
31. Sokoloski K.J., et al. Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells. Cell Host Microbe 2010, 8:196-207.
32. Korf M., et al. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. J. Hepatol. 2005, 43:225-234.
33. Cumming S.A., et al. The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells. Virology 2009, 383:142-149.
34. Bodem J., et al. Foamy virus nuclear RNA export is distinct from that of other retroviruses. J. Virol. 2011, 85:2333-2341.
35. Kuroshima T., et al. Viral-mediated stabilization of AU-rich element containing mRNA contributes to cell transformation. Oncogene 2011, 10.1038/onc.2011.14.
36. Ji X., et al. The 3' untranslated region complex involved in stabilization of human alpha-globin mRNA assembles in the nucleus and serves an independent role as a splice enhancer. Mol. Cell. Biol. 2007, 27:3290-3302.
37. Waggoner S.A., et al. Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest. J. Biol. Chem. 2009, 284:9039-9049.
38. Sean P., et al. Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity. Virology 2009, 389:45-58.
39. Spear A., et al. Protein-RNA tethering: the role of poly(C) binding protein 2 in poliovirus RNA replication. Virology 2008, 374:280-291.
40. Mai Y., Gao G. Expression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging. PLoS ONE 2010, 5:e15881.
41. Withers J.B., Beemon K.L. Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon. Retrovirology 2010, 7:65.
42. Reguera J., et al. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog. 2010, 6:e1001101.
43. Schulz O., et al. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 2010, 7:354-361.
44. Launer-Felty K., et al. Magnesium-dependent interaction of PKR with adenovirus VAI. J. Mol. Biol. 2010, 402:638-644.
45. Borja M.S., et al. Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition. RNA 2011, 17:278-290.
46. Dougherty J.D., et al. Poliovirus-mediated disruption of cytoplasmic processing bodies. J. Virol. 2011, 85:64-75.
47. Bonderoff J.M., et al. Cleavage of poly(A)-binding protein by poliovirus 3C proteinase inhibits viral internal ribosome entry site-mediated translation. J. Virol. 2008, 82:9389-9399.
48. Santhakumar D., et al. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc. Natl. Acad. Sci. U.S.A. 2010, 2107:13830-13835.
49. Cazalla D., et al. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 2010, 328:1563-1566.
50. Child S.J., et al. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 2004, 78:197-205.
51. Luhtala N., Parker R. T2 Family ribonucleases: ancient enzymes with diverse roles. Trends Biochem. Sci. 2010, 35:253-259.
52. Henneke M., et al. RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat. Genet. 2009, 41:773-775.
53. George C.X., et al. Adenosine deaminases acting on RNA, RNA editing, and interferon action. J. Interferon Cytokine Res. 2011, 31:99-117.
54. Bagnéris C., et al. Crystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoff. Nucleic Acids Res. 2011, 10.1093/nar/gkr111.
55. Lee Y.J., Glaunsinger B.A. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction. PLoS Biol. 2009, 7:e1000107.
56. Kumar G.R., Glaunsinger B.A. Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA. Mol. Cell. Biol. 2010, 30:4996-5008.
57. Saffran H.A., et al. Evidence for translational regulation by the herpes simplex virus virion host shutoff protein. J. Virol. 2010, 84:6041-6049.
58. Buisson M., et al. A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. J. Mol. Biol. 2009, 391:717-728.
59. Parrish S., et al. Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2139-2144.
60. Parrish S., Moss B. Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses. J. Virol. 2007, 81:12973-12978.
61. Soulière M.F., et al. Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme. Nucleic Acids Res. 2010, 38:7599-7610.
62. Morin B., et al. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog. 2010, 6:e1001038.
63. Tang J., et al. The structural basis of recognition and removal of cellular mRNA 7-methyl G 'caps' by a viral capsid protein: a unique viral response to host defense. J. Mol. Recognit. 2005, 18:158-168.
64. Fujimura T., Esteban R. Yeast double-stranded RNA virus L-A deliberately synthesizes RNA transcripts with 5'-diphosphate. J. Biol. Chem. 2010, 285:22911-22918.
65. Kamitani W., et al. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat. Struct. Mol. Biol. 2009, 16:1134-1140.
66. Hastie K.M., et al. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2396-2401.
67. Qi L., et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 2010, 468:779-783.
68. Minskaia E., et al. Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5108-5113.
69. Steitz T.A., Steitz J.A. A general two-metal-ion mechanism for catalytic RNA. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:6498-6502.
70. Pijlman G.P., et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 2008, 4:579-591.
71. Funk A., et al. RNA structures required for production of subgenomic flavivirus RNA. J. Virol. 2010, 84:11407-11417.
72. Silva P.A., et al. An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1. J. Virol. 2010, 284:11395-11406.
73. Jopling C.L., et al. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008, 4:77-85.
74. Lanford R.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
75. Machlin E.S., et al. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3193-3198.
76. Eckerle L.D., et al. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010, 6:e1000896.
77. Eckerle L.D., et al. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 2007, 81:12135-12144.
78. Siemetzki U., et al. Identification of RNA instability elements in Borna disease virus. Virus Res. 2009, 144:27-34.
79. Whelan S.P., et al. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 2004, 283:61-119.
80. Dutko J.A., et al. 5' to 3' mRNA decay factors colocalize with Ty1 gag and human APOBEC3G and promote Ty1 retrotransposition. J. Virol. 2010, 84:5052-5066.
81. Ajamian L., et al. Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA 2008, 14:914-927.
82. Wilusz C.J., Wilusz J. Eukaryotic Lsm proteins: lessons from bacteria. Nat. Struct. Mol. Biol. 2005, 12:1031-1036.
83. Kedersha N., Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol. 2007, 431:61-81.
84. Totaro A., et al. The human Pat1b protein: a novel mRNA deadenylation factor identified by a new immunoprecipitation technique. Nucleic Acids Res. 2011, 39:635-647.
85. Galão R.P., et al. LSm1-7 complexes bind to specific sites in viral RNA genomes and regulate their translation and replication. RNA 2010, 16:817-827.
86. Scheller N., et al. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13517-13522.
87. Jangra R.K., et al. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J. Virol. 2010, 84:6810-6824.
88. Bergman N., et al. Lsm proteins bind and stabilize RNAs containing 5' poly(A) tracts. Nat. Struct. Mol. Biol. 2007, 14:824-831.